Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib.
Jaeschke
Roman
R
Gajewski
Piotr
P
Brozek
Jan
J
D001241:Aspirin / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D018849:Controlled Clinical Trials as Topic / Q000379:methods / Q000592:standards; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards; D013450:Sulfones; D013927:Thrombosis / Q000139:chemically induced
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D001241:Aspirin